Clinical and prognostic implications of an immune‐related risk model based on TP53 status in lung adenocarcinoma

TP53 mutation is the most widespread mutation in lung adenocarcinoma (LUAD). Meanwhile, p53 (encoded by TP53) has recently been implicated in immune responses. However, it is still unknown whether TP53 mutation remodels the tumour microenvironment to influence tumour progression and prognosis in LUA...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Xuming, Chen, Qiang, Wang, Jifan, Mao, Qixing, Xia, Wenjie, Xu, Lin, Jiang, Feng, Dong, Gaochao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743672/
https://www.ncbi.nlm.nih.gov/pubmed/34877770
http://dx.doi.org/10.1111/jcmm.17097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743672/
https://www.ncbi.nlm.nih.gov/pubmed/34877770
http://dx.doi.org/10.1111/jcmm.17097

Ejemplares similares